Loading…
Lower beta cell function relates to sustained higher glycated albumin to glycated hemoglobin ratio in Japanese patients with type 2 diabetes
The aim of this study was to clarify the relationship between baseline beta cell function and future glycated albumin (GA) to glycated hemoglobin ratio (GA/HbA1c) in patients with type 2 diabetes. In our retrospective cohort, 210 type 2 diabetic patients who had been admitted to our hospital and in...
Saved in:
Published in: | Endocrine Journal 2014, Vol.61(2), pp.149-157 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c498t-1112cbd0636c035f60f3fe44b106d634c1199c42d32cc5f907639a2135fc1e5d3 |
---|---|
cites | cdi_FETCH-LOGICAL-c498t-1112cbd0636c035f60f3fe44b106d634c1199c42d32cc5f907639a2135fc1e5d3 |
container_end_page | 157 |
container_issue | 2 |
container_start_page | 149 |
container_title | Endocrine Journal |
container_volume | 61 |
creator | Saisho, Yoshifumi Tanaka, Kumiko Abe, Takayuki Kawai, Toshihide Itoh, Hiroshi |
description | The aim of this study was to clarify the relationship between baseline beta cell function and future glycated albumin (GA) to glycated hemoglobin ratio (GA/HbA1c) in patients with type 2 diabetes. In our retrospective cohort, 210 type 2 diabetic patients who had been admitted to our hospital and in whom HbA1c and GA had been measured at baseline and 2 years after admission were included in this study. Baseline beta cell function was assessed by postprandial C-peptide immunoreactivity index (PCPRI) during admission. With intensification of treatment during admission, HbA1c and GA were significantly decreased 1 year and 2 years after admission. While baseline HbA1c was not significantly correlated with HbA1c after 2 years, baseline GA/HbA1c was strongly correlated with GA/HbA1c after 2 years (r = 0.575, P |
doi_str_mv | 10.1507/endocrj.EJ13-0376 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1504141889</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1504141889</sourcerecordid><originalsourceid>FETCH-LOGICAL-c498t-1112cbd0636c035f60f3fe44b106d634c1199c42d32cc5f907639a2135fc1e5d3</originalsourceid><addsrcrecordid>eNo9kcFu3CAQhlHVqtmkfYBeKo69OGUAe82xitI00Uq9tGcLw3jNyjYuYEX7Dn3oYu3WF0A_3_yamZ-QT8DuoWT7rzhZb8Lp_vEFRMHEvnpDdiBkXchSsrdkxxTURa1KdUNuYzwxJkQpxXtywyUHXtewI38P_hUDbTFpanAYaLdMJjk_0YCDThhp8jQuMWk3oaW9O_YZPw5nkz8t1UO7jG5aoU3rcfTHwbdZDjpb0fx40bOeMCKds4JTivTVpZ6m84yUU-t0bgDjB_Ku00PEj9f7jvz-_vjr4Udx-Pn0_PDtUBip6lQAADetZZWoDBNlV7FOdChlC6yylZAGQCkjuRXcmLJTbF8JpTlk1ACWVtyRLxffOfg_C8bUjC6u0-ce_RKbvFwJEupaZRQuqAk-xoBdMwc36nBugK3cvrmG0KwhNGsIuebz1X5pR7Rbxf-tZ-DpApzyXo-4ATokZwbcLCto-Hps1htheh0yJv4BpzGgXA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1504141889</pqid></control><display><type>article</type><title>Lower beta cell function relates to sustained higher glycated albumin to glycated hemoglobin ratio in Japanese patients with type 2 diabetes</title><source>J-STAGE (Japan Science & Technology Information Aggregator, Electronic) - Open Access English articles</source><creator>Saisho, Yoshifumi ; Tanaka, Kumiko ; Abe, Takayuki ; Kawai, Toshihide ; Itoh, Hiroshi</creator><creatorcontrib>Saisho, Yoshifumi ; Tanaka, Kumiko ; Abe, Takayuki ; Kawai, Toshihide ; Itoh, Hiroshi</creatorcontrib><description>The aim of this study was to clarify the relationship between baseline beta cell function and future glycated albumin (GA) to glycated hemoglobin ratio (GA/HbA1c) in patients with type 2 diabetes. In our retrospective cohort, 210 type 2 diabetic patients who had been admitted to our hospital and in whom HbA1c and GA had been measured at baseline and 2 years after admission were included in this study. Baseline beta cell function was assessed by postprandial C-peptide immunoreactivity index (PCPRI) during admission. With intensification of treatment during admission, HbA1c and GA were significantly decreased 1 year and 2 years after admission. While baseline HbA1c was not significantly correlated with HbA1c after 2 years, baseline GA/HbA1c was strongly correlated with GA/HbA1c after 2 years (r = 0.575, P <0.001). When the patients were divided into two groups according to median PCPRI, patients with low PCPRI showed higher GA/HbA1c both at baseline and after 2 years compared to those with high PCPRI. There was a significant negative correlation between PCPRI and GA/HbA1c after 2 years (r = -0.379, P <0.001). Multiple regression analysis revealed that PCPRI was an independent predictor of GA/HbA1c after 2 years. In conclusion, our findings suggest that lower beta cell function is associated with sustained higher GA/HbA1c ratio in patients with type 2 diabetes.</description><identifier>ISSN: 0918-8959</identifier><identifier>EISSN: 1348-4540</identifier><identifier>DOI: 10.1507/endocrj.EJ13-0376</identifier><identifier>PMID: 24212881</identifier><language>eng</language><publisher>Japan: The Japan Endocrine Society</publisher><subject>Aged ; Asian Continental Ancestry Group ; Beta cell function ; C-peptide ; C-Peptide - blood ; Diabetes Mellitus, Type 2 - physiopathology ; Female ; Glycated albumin ; Glycated hemoglobin ; Glycated Hemoglobin A - metabolism ; Humans ; Insulin-Secreting Cells - physiology ; Male ; Middle Aged ; Regression Analysis ; Retrospective Studies ; Serum Albumin - metabolism ; Type 2 diabetes</subject><ispartof>Endocrine Journal, 2014, Vol.61(2), pp.149-157</ispartof><rights>The Japan Endocrine Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c498t-1112cbd0636c035f60f3fe44b106d634c1199c42d32cc5f907639a2135fc1e5d3</citedby><cites>FETCH-LOGICAL-c498t-1112cbd0636c035f60f3fe44b106d634c1199c42d32cc5f907639a2135fc1e5d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1875,4009,27902,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24212881$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Saisho, Yoshifumi</creatorcontrib><creatorcontrib>Tanaka, Kumiko</creatorcontrib><creatorcontrib>Abe, Takayuki</creatorcontrib><creatorcontrib>Kawai, Toshihide</creatorcontrib><creatorcontrib>Itoh, Hiroshi</creatorcontrib><title>Lower beta cell function relates to sustained higher glycated albumin to glycated hemoglobin ratio in Japanese patients with type 2 diabetes</title><title>Endocrine Journal</title><addtitle>Endocr J</addtitle><description>The aim of this study was to clarify the relationship between baseline beta cell function and future glycated albumin (GA) to glycated hemoglobin ratio (GA/HbA1c) in patients with type 2 diabetes. In our retrospective cohort, 210 type 2 diabetic patients who had been admitted to our hospital and in whom HbA1c and GA had been measured at baseline and 2 years after admission were included in this study. Baseline beta cell function was assessed by postprandial C-peptide immunoreactivity index (PCPRI) during admission. With intensification of treatment during admission, HbA1c and GA were significantly decreased 1 year and 2 years after admission. While baseline HbA1c was not significantly correlated with HbA1c after 2 years, baseline GA/HbA1c was strongly correlated with GA/HbA1c after 2 years (r = 0.575, P <0.001). When the patients were divided into two groups according to median PCPRI, patients with low PCPRI showed higher GA/HbA1c both at baseline and after 2 years compared to those with high PCPRI. There was a significant negative correlation between PCPRI and GA/HbA1c after 2 years (r = -0.379, P <0.001). Multiple regression analysis revealed that PCPRI was an independent predictor of GA/HbA1c after 2 years. In conclusion, our findings suggest that lower beta cell function is associated with sustained higher GA/HbA1c ratio in patients with type 2 diabetes.</description><subject>Aged</subject><subject>Asian Continental Ancestry Group</subject><subject>Beta cell function</subject><subject>C-peptide</subject><subject>C-Peptide - blood</subject><subject>Diabetes Mellitus, Type 2 - physiopathology</subject><subject>Female</subject><subject>Glycated albumin</subject><subject>Glycated hemoglobin</subject><subject>Glycated Hemoglobin A - metabolism</subject><subject>Humans</subject><subject>Insulin-Secreting Cells - physiology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Regression Analysis</subject><subject>Retrospective Studies</subject><subject>Serum Albumin - metabolism</subject><subject>Type 2 diabetes</subject><issn>0918-8959</issn><issn>1348-4540</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNo9kcFu3CAQhlHVqtmkfYBeKo69OGUAe82xitI00Uq9tGcLw3jNyjYuYEX7Dn3oYu3WF0A_3_yamZ-QT8DuoWT7rzhZb8Lp_vEFRMHEvnpDdiBkXchSsrdkxxTURa1KdUNuYzwxJkQpxXtywyUHXtewI38P_hUDbTFpanAYaLdMJjk_0YCDThhp8jQuMWk3oaW9O_YZPw5nkz8t1UO7jG5aoU3rcfTHwbdZDjpb0fx40bOeMCKds4JTivTVpZ6m84yUU-t0bgDjB_Ku00PEj9f7jvz-_vjr4Udx-Pn0_PDtUBip6lQAADetZZWoDBNlV7FOdChlC6yylZAGQCkjuRXcmLJTbF8JpTlk1ACWVtyRLxffOfg_C8bUjC6u0-ce_RKbvFwJEupaZRQuqAk-xoBdMwc36nBugK3cvrmG0KwhNGsIuebz1X5pR7Rbxf-tZ-DpApzyXo-4ATokZwbcLCto-Hps1htheh0yJv4BpzGgXA</recordid><startdate>2014</startdate><enddate>2014</enddate><creator>Saisho, Yoshifumi</creator><creator>Tanaka, Kumiko</creator><creator>Abe, Takayuki</creator><creator>Kawai, Toshihide</creator><creator>Itoh, Hiroshi</creator><general>The Japan Endocrine Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2014</creationdate><title>Lower beta cell function relates to sustained higher glycated albumin to glycated hemoglobin ratio in Japanese patients with type 2 diabetes</title><author>Saisho, Yoshifumi ; Tanaka, Kumiko ; Abe, Takayuki ; Kawai, Toshihide ; Itoh, Hiroshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c498t-1112cbd0636c035f60f3fe44b106d634c1199c42d32cc5f907639a2135fc1e5d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Aged</topic><topic>Asian Continental Ancestry Group</topic><topic>Beta cell function</topic><topic>C-peptide</topic><topic>C-Peptide - blood</topic><topic>Diabetes Mellitus, Type 2 - physiopathology</topic><topic>Female</topic><topic>Glycated albumin</topic><topic>Glycated hemoglobin</topic><topic>Glycated Hemoglobin A - metabolism</topic><topic>Humans</topic><topic>Insulin-Secreting Cells - physiology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Regression Analysis</topic><topic>Retrospective Studies</topic><topic>Serum Albumin - metabolism</topic><topic>Type 2 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Saisho, Yoshifumi</creatorcontrib><creatorcontrib>Tanaka, Kumiko</creatorcontrib><creatorcontrib>Abe, Takayuki</creatorcontrib><creatorcontrib>Kawai, Toshihide</creatorcontrib><creatorcontrib>Itoh, Hiroshi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Endocrine Journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Saisho, Yoshifumi</au><au>Tanaka, Kumiko</au><au>Abe, Takayuki</au><au>Kawai, Toshihide</au><au>Itoh, Hiroshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lower beta cell function relates to sustained higher glycated albumin to glycated hemoglobin ratio in Japanese patients with type 2 diabetes</atitle><jtitle>Endocrine Journal</jtitle><addtitle>Endocr J</addtitle><date>2014</date><risdate>2014</risdate><volume>61</volume><issue>2</issue><spage>149</spage><epage>157</epage><pages>149-157</pages><issn>0918-8959</issn><eissn>1348-4540</eissn><abstract>The aim of this study was to clarify the relationship between baseline beta cell function and future glycated albumin (GA) to glycated hemoglobin ratio (GA/HbA1c) in patients with type 2 diabetes. In our retrospective cohort, 210 type 2 diabetic patients who had been admitted to our hospital and in whom HbA1c and GA had been measured at baseline and 2 years after admission were included in this study. Baseline beta cell function was assessed by postprandial C-peptide immunoreactivity index (PCPRI) during admission. With intensification of treatment during admission, HbA1c and GA were significantly decreased 1 year and 2 years after admission. While baseline HbA1c was not significantly correlated with HbA1c after 2 years, baseline GA/HbA1c was strongly correlated with GA/HbA1c after 2 years (r = 0.575, P <0.001). When the patients were divided into two groups according to median PCPRI, patients with low PCPRI showed higher GA/HbA1c both at baseline and after 2 years compared to those with high PCPRI. There was a significant negative correlation between PCPRI and GA/HbA1c after 2 years (r = -0.379, P <0.001). Multiple regression analysis revealed that PCPRI was an independent predictor of GA/HbA1c after 2 years. In conclusion, our findings suggest that lower beta cell function is associated with sustained higher GA/HbA1c ratio in patients with type 2 diabetes.</abstract><cop>Japan</cop><pub>The Japan Endocrine Society</pub><pmid>24212881</pmid><doi>10.1507/endocrj.EJ13-0376</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0918-8959 |
ispartof | Endocrine Journal, 2014, Vol.61(2), pp.149-157 |
issn | 0918-8959 1348-4540 |
language | eng |
recordid | cdi_proquest_miscellaneous_1504141889 |
source | J-STAGE (Japan Science & Technology Information Aggregator, Electronic) - Open Access English articles |
subjects | Aged Asian Continental Ancestry Group Beta cell function C-peptide C-Peptide - blood Diabetes Mellitus, Type 2 - physiopathology Female Glycated albumin Glycated hemoglobin Glycated Hemoglobin A - metabolism Humans Insulin-Secreting Cells - physiology Male Middle Aged Regression Analysis Retrospective Studies Serum Albumin - metabolism Type 2 diabetes |
title | Lower beta cell function relates to sustained higher glycated albumin to glycated hemoglobin ratio in Japanese patients with type 2 diabetes |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T04%3A14%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lower%20beta%20cell%20function%20relates%20to%20sustained%20higher%20glycated%20albumin%20to%20glycated%20hemoglobin%20ratio%20in%20Japanese%20patients%20with%20type%202%20diabetes&rft.jtitle=Endocrine%20Journal&rft.au=Saisho,%20Yoshifumi&rft.date=2014&rft.volume=61&rft.issue=2&rft.spage=149&rft.epage=157&rft.pages=149-157&rft.issn=0918-8959&rft.eissn=1348-4540&rft_id=info:doi/10.1507/endocrj.EJ13-0376&rft_dat=%3Cproquest_cross%3E1504141889%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c498t-1112cbd0636c035f60f3fe44b106d634c1199c42d32cc5f907639a2135fc1e5d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1504141889&rft_id=info:pmid/24212881&rfr_iscdi=true |